Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Medical College of Wisconsin
Eastern Cooperative Oncology Group
Stanford University
Turku University Hospital
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
Institut Cancerologie de l'Ouest
Haukeland University Hospital
Dana-Farber Cancer Institute
Cedars-Sinai Medical Center
Sir Mortimer B. Davis - Jewish General Hospital
Institut Bergonié
Shandong Cancer Hospital and Institute
Institut Bergonié
Hospital do Coracao
Severance Hospital
University Hospital A Coruña
Federal University of São Paulo
Dana-Farber Cancer Institute
The First Affiliated Hospital with Nanjing Medical University
Beni-Suef University
Seoul National University Hospital
Universitaire Ziekenhuizen KU Leuven
Indiana University
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Zagazig University
Maastricht Radiation Oncology
Peking Union Medical College Hospital
Gangnam Severance Hospital
University of Maryland, Baltimore
European Institute of Oncology
University College, London
Hospices Civils de Lyon
Kahramanmaras Sutcu Imam University
Albert Einstein College of Medicine
Amgen
Federation of Breast Diseases Societies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
King Abdulaziz University
Invuity, Inc.
Karolinska University Hospital
Jilin University
Gustave Roussy, Cancer Campus, Grand Paris
Washington University School of Medicine
Washington University School of Medicine
Barretos Cancer Hospital
Sun Yat-sen University
University of Arkansas
Vanderbilt-Ingram Cancer Center